- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.04. | Longevity Health to combine with 20/20 BioLabs in all-stock deal | 1 | Seeking Alpha | ||
| LONGEVITY HEALTH Aktie jetzt für 0€ handeln | |||||
| 14.04. | Longevity Health Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.04. | Longevity Health Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 31.03. | Longevity Health Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 26.03. | Longevity Health Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Carmell Corp. Rebrands, Announces Growth Initiatives And Management Changes | - | RTTNews | ||
| 05.03. | Longevity Health Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 24.01. | Carmell Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture to Carmell Corporation | 179 | GlobeNewswire (Europe) | NEWPORT BEACH, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (formerly Elevai Labs Inc.) (the "Company" or "PMGC") (Nasdaq: ELAB) a diversified holding company today announced the closing... ► Artikel lesen | |
| 16.01. | Carmell Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 03.01. | Carmell Corporation Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out | 268 | GlobeNewswire (Europe) | PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced... ► Artikel lesen | |
| 02.01. | Why Biotechnology Company Carmell Shares Are Rocketing On Thursday | 16 | Benzinga.com | ||
| 02.01. | Carmell's earning potential swells with Elevai acquisition | 3 | Seeking Alpha | ||
| 02.01. | Carmell Corporation acquires Elevai assets for $1.1M | 3 | Investing.com | ||
| 02.01. | Carmell Corporation übernimmt Elevai-Vermögenswerte für 1,1 Mio. US-Dollar | 2 | Investing.com Deutsch | ||
| 02.01. | Carmell Corporation Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a wholly owned subsidiary of PMGC Holdings Inc. | 574 | GlobeNewswire (Europe) | PITTSBURGH, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced... ► Artikel lesen | |
| 31.12.24 | Carmell Corp - 8-K, Current Report | - | SEC Filings | ||
| 24.12.24 | Why Biotechnology Company Carmell Shares Are Seeing Blue Skies Tuesday? | 3 | Benzinga.com | ||
| 24.12.24 | Carmell announces PIPE investment, shares up more than 20% | 1 | Seeking Alpha | ||
| 24.12.24 | Carmell Corporation Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out | 63 | GlobeNewswire (Europe) | PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced... ► Artikel lesen |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALATIN TECHNOLOGIES | 0,089 | +5,58 % | XFRA PTN: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPALATIN TECHS DL-... ► Artikel lesen | |
| BIOXXMED | 0,410 | -8,89 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 31.03.2025 | The following instruments on Xetra do have their last trading day on 31.03.2025.Die folgenden Instrumente auf Xetra haben ihren letzten Handelstag am 31.03.2025.ISIN NameDE000A4BGGE4 bioXXmed AG ► Artikel lesen | |
| VIVOSIM LABS | 1,930 | -100,00 % | VivoSim Labs, INC. - 8-K, Current Report | ||
| OCUGEN | 0,588 | -1,01 % | Ocugen Provides Business Update with First Quarter 2025 Financial Results | Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026Anticipate... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem gibt Finanzierung mittels Wandelschuldverschreibung bekannt | Vancouver, British Columbia, 22. April 2025 / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (OTC: SRBCF) ("Sirona" oder das "Unternehmen") gibt eine nicht vermittelte Privatplatzierung... ► Artikel lesen | |
| BIO-GATE | 0,640 | 0,00 % | Bio-Gate startet Produkt-Launch für Tierpflege in den USA | Bio-Gate hat die Präsenz im nordamerikanischen Veterinärmarkt ausgebaut. Gemeinsam mit einem internationalen Anbieter bringt Bio-Gate neue Tierpflegeprodukte zur Haut-, Ohr- und Wundbehandlung in die... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,602 | -1,31 % | Evotecs KI-Goldgrube, Defence Therapeutics Milliarden-Märkte, Novo Nordisks Diät-Revolution: So verdienen Anleger mit | Die Gesundheitsbranche befindet sich im Umbruch. Algorithmen beschleunigen die Arzneimittelforschung um Jahre, Milliarden fließen in personalisierte Therapien, und Börsen feiern Biotech-Aktien. Doch... ► Artikel lesen | |
| VAXART | 0,348 | -6,61 % | Vaxart, Inc.: Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress | Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting as Recommended by Leading Independent Proxy Advisory Firms SOUTH SAN FRANCISCO, Calif., May 05, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| BURCON NUTRASCIENCE | 0,062 | +0,32 % | Burcon NutraScience Corporation: Burcon Integrates Protein Technologies at Galesburg Facility | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of... ► Artikel lesen | |
| CELLECTAR BIOSCIENCES | 0,226 | +2,73 % | Cellectar Biosciences, Inc.: Cellectar Announces Plan to Explore Strategic Alternatives | FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization... ► Artikel lesen | |
| AFFIMED | 0,530 | -100,00 % | Affimed N.V.: Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement | MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer,... ► Artikel lesen | |
| AIM IMMUNOTECH | 0,073 | -100,00 % | AIM ImmunoTech Inc.: AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists | ||
| IMMUNIC | 0,919 | +2,80 % | EQS-News: Immunic AG: Immunic to Participate in Scientific and Industry Conferences in May | Issuer: Immunic AG
/ Key word(s): Conference
Immunic to Participate in Scientific and Industry Conferences in May
02.05.2025 / 12:30 CET/CEST
The issuer is solely responsible... ► Artikel lesen | |
| T2 BIOSYSTEMS | 0,145 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.02.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.02.2025.ISIN NameCA24703H1029 DELIVRA... ► Artikel lesen | |
| CEL-SCI | 0,216 | -1,28 % | CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer | VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) reported financial results for the fiscal year ended September 30, 2024, as well as key clinical and corporate developments.
"We... ► Artikel lesen |
LONGEVITY HEALTH HOLDINGS INC gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,150 Euro und damit -0,40 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LONGEVITY HEALTH HOLDINGS INC finden Sie auf Wallstreet Online.